GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Nazerai, Loulieta  (3)
  • 2015-2019  (3)
  • 1
    Online Resource
    Online Resource
    The American Association of Immunologists ; 2017
    In:  The Journal of Immunology Vol. 198, No. 1_Supplement ( 2017-05-01), p. 147.11-147.11
    In: The Journal of Immunology, The American Association of Immunologists, Vol. 198, No. 1_Supplement ( 2017-05-01), p. 147.11-147.11
    Abstract: Current influenza vaccines are inducing antibody-mediated immunity toward the surface proteins hemagglutinin and neuraminidase. High variability of these proteins results in costly annual evaluation and production of new vaccines, not providing protection against heterosubtypic or emerging pandemic strains. Consequently, there is a need for a new universal influenza vaccine strategy. Unlike the surface proteins, the internal proteins of influenza are highly conserved. By vaccinating systemically and locally with nucleoprotein encoded in an adenovirus (AdNP) we could induce a protective CD8 T-cell response, that lasted up to at least 8 month post vaccination. To increase the breadth of our vaccine by combining construct, we studied the vaccine potential of another influenza protein. We showed that an adenovirus encoding PB1 elicits high numbers of antigen-specific CD8 T cells in mice. However, in vivo killing of peptide loaded cells was lower in PB1-vaccinated mice than in NP-vaccinated mice. This correlated with a poorer protection against challenge. To explain this, T cells from vaccinated mice were co-incubated with naïve splenocytes loaded with decreasing concentrations of peptide. If T cells were immediately added to the co-cultures, similar dose/response curves regarding IFNγ production was observed. However, if the T cells were added 6 hours after loading, cells from PB1-vaccinated mice required a much higher initial concentration of peptide to be activated compared with NP specific cells, indicating a lower stability of the MHC-PB1peptide complex. These results underscore that not only are T-cell quality and quantity crucial to consider in future vaccine design, but also MHC-peptide interactions.
    Type of Medium: Online Resource
    ISSN: 0022-1767 , 1550-6606
    RVK:
    RVK:
    Language: English
    Publisher: The American Association of Immunologists
    Publication Date: 2017
    detail.hit.zdb_id: 1475085-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Frontiers Media SA ; 2018
    In:  Frontiers in Immunology Vol. 9 ( 2018-3-22)
    In: Frontiers in Immunology, Frontiers Media SA, Vol. 9 ( 2018-3-22)
    Type of Medium: Online Resource
    ISSN: 1664-3224
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2018
    detail.hit.zdb_id: 2606827-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    MDPI AG ; 2019
    In:  Viruses Vol. 11, No. 1 ( 2019-01-06), p. 29-
    In: Viruses, MDPI AG, Vol. 11, No. 1 ( 2019-01-06), p. 29-
    Abstract: The worldwide attention that the Zika virus (ZIKV) attracted, following its declaration as a Public Health Emergency of International concern by WHO in 2016, has led to a large collective effort by the international scientific community to understand its biology. Despite the mild symptoms caused by ZIKV in most infected people, the virus displays a number of worrying features, such as its ability to cause transplacental infection, fetal abnormalities and vector independent transmission through body fluids. In addition, the virus has been associated with the induction of Guillain-Barre syndrome in a number of infected individuals. With travelling, the virus has spread outside the original ZIKV endemic areas making it imperative to find ways to control it. Thus far, the large number of animal models developed to study ZIKV pathogenesis have proven to be valuable tools in understanding how the virus replicates and manifests itself in the host, its tissue tropism and the type of immune responses it induces. Still, vital questions, such as the molecular mechanisms of ZIKV persistence and the long-term consequences of ZIKV infection in the developing brain, remain unanswered. Here, we reviewed and discussed the major and most recent findings coming from animal studies and their implications for a ZIKV vaccine design.
    Type of Medium: Online Resource
    ISSN: 1999-4915
    Language: English
    Publisher: MDPI AG
    Publication Date: 2019
    detail.hit.zdb_id: 2516098-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...